TC
ABEO icon

Truvestments Capital’s Abeona Therapeutics ABEO Stock Holding History

Truvestments Capital’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.4K Sell
9,774
-533
-5% -$2.93K 0.01% 493
2026
Q1 		$46.2K Hold
10,307
– – 0.01% 512
2025
Q4 		$54.3K Buy
10,307
+6,770
+191% +$34.1K 0.01% 434
2025
Q3 		$18.7K Buy
3,537
+778
+28% +$4.93K ﹤0.01% 611
2025
Q2 		$15.7K Buy
2,759
+2,708
+5,310% +$15.4K ﹤0.01% 580
2025
Q1 		$243 Hold
51
– – ﹤0.01% 986
2024
Q4 		$284 Hold
51
– – ﹤0.01% 972
2024
Q3 		$322 Buy
+51
New +$266 ﹤0.01% 889
2024
Q2 		– Sell
-51
Closed -$370 – 222
2024
Q1 		$370 Hold
51
– – ﹤0.01% 687
2023
Q4 		$256 Hold
51
– – ﹤0.01% 760
2023
Q3 		$215 Hold
51
– – ﹤0.01% 663
2023
Q2 		$206 Hold
51
– – ﹤0.01% 672
2023
Q1 		$144 Hold
51
– – ﹤0.01% 657
2022
Q4 		$157 Buy
+51
New +$191 ﹤0.01% 901
2022
Q3 		– Sell
-55
Closed – – 617
2022
Q2 		$0 Buy
+55
New +$278 ﹤0.01% 639
2022
Q1 		– Sell
-55
Closed – – 180
2021
Q4 		$0 Hold
55
– – ﹤0.01% 600
2021
Q3 		$2K Hold
55
– – ﹤0.01% 529
2021
Q2 		$2K Hold
55
– – ﹤0.01% 539
2021
Q1 		$3K Buy
55
+44
+400% +$2.42K ﹤0.01% 560
2020
Q4 		$0 Buy
+11
New +$375 ﹤0.01% 601
2020
Q3 		– Sell
-11
Closed – – 312
2020
Q2 		$0 Buy
+11
New +$760 ﹤0.01% 565
2019
Q4 		– Sell
-19
Closed -$1K – 141
2019
Q3 		$1K Sell
19
-3
-14% -$225 ﹤0.01% 676
2019
Q2 		$3K Hold
22
– – ﹤0.01% 658
2019
Q1 		$4K Buy
+22
New +$3.93K ﹤0.01% 616
2018
Q3 		$7K Buy
+22
New +$7.8K ﹤0.01% 694

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Truvestments Capital's ABEO Position: Q2 2026 in Review

Truvestments Capital reduced its Abeona Therapeutics (ABEO) stake by 5.2% in Q2 2026, selling an estimated $2.93K and leaving 9,774 shares worth $60.4K. The position accounts for 0.01% of the portfolio, ranked #493.

Truvestments Capital first reported a position in ABEO in Q3 2018 and has held it in 25 quarters since. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Truvestments Capital held 9,774 shares of Abeona Therapeutics worth $60.4K as of Q2 2026.
  • Truvestments Capital sold 533 Abeona Therapeutics shares in Q2 2026, an estimated $2.93K.
  • Abeona Therapeutics made up 0.01% of Truvestments Capital's portfolio in Q2 2026, its #493 holding.
  • Truvestments Capital first reported a position in Abeona Therapeutics in Q3 2018 and has held it in 25 quarters since.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.